State Street’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.23B | Buy |
16,731,668
+117,907
| +0.7% | +$64M | 0.28% | 63 |
|
|
2025
Q4 | $9.63B | Buy |
16,613,761
+229,630
| +1% | +$130M | 0.32% | 48 |
|
|
2025
Q3 | $7.95B | Sell |
16,384,131
-96,834
| -0.6% | -$45.1M | 0.28% | 62 |
|
|
2025
Q2 | $6.69B | Sell |
16,480,965
-58,524
| -0.4% | -$24.5M | 0.25% | 71 |
|
|
2025
Q1 | $8.24B | Buy |
16,539,489
+91,461
| +0.6% | +$49.5M | 0.34% | 48 |
|
|
2024
Q4 | $8.56B | Buy |
16,448,028
+129,067
| +0.8% | +$71M | 0.34% | 47 |
|
|
2024
Q3 | $10.1B | Buy |
16,318,961
+124,996
| +0.8% | +$74M | 0.41% | 39 |
|
|
2024
Q2 | $8.96B | Sell |
16,193,965
-389,979
| -2% | -$223M | 0.39% | 42 |
|
|
2024
Q1 | $9.65B | Buy |
16,583,944
+107,060
| +0.6% | +$60.1M | 0.43% | 38 |
|
|
2023
Q4 | $8.75B | Buy |
16,476,884
+835,295
| +5% | +$404M | 0.43% | 40 |
|
|
2023
Q3 | $7.92B | Sell |
15,641,589
-475,367
| -3% | -$253M | 0.44% | 37 |
|
|
2023
Q2 | $8.41B | Buy |
16,116,956
+55,458
| +0.3% | +$29.9M | 0.44% | 36 |
|
|
2023
Q1 | $9.26B | Sell |
16,061,498
-223,763
| -1% | -$126M | 0.52% | 32 |
|
|
2022
Q4 | $8.97B | Buy |
16,285,261
+126,385
| +0.8% | +$67M | 0.53% | 31 |
|
|
2022
Q3 | $8.2B | Buy |
16,158,876
+135,437
| +0.8% | +$75.8M | 0.52% | 31 |
|
|
2022
Q2 | $8.71B | Sell |
16,023,439
-194,196
| -1% | -$107M | 0.52% | 31 |
|
|
2022
Q1 | $9.58B | Sell |
16,217,635
-5,538
| -0% | -$3.18M | 0.47% | 33 |
|
|
2021
Q4 | $10.8B | Buy |
16,223,173
+529,712
| +3% | +$331M | 0.51% | 29 |
|
|
2021
Q3 | $8.97B | Buy |
15,693,461
+139,803
| +0.9% | +$76.7M | 0.47% | 33 |
|
|
2021
Q2 | $7.85B | Buy |
15,553,658
+318,930
| +2% | +$150M | 0.41% | 46 |
|
|
2021
Q1 | $6.96B | Sell |
15,234,728
-544,269
| -3% | -$260M | 0.4% | 50 |
|
|
2020
Q4 | $7.35B | Sell |
15,778,997
-515,227
| -3% | -$242M | 0.45% | 46 |
|
|
2020
Q3 | $7.2B | Sell |
16,294,224
-268,082
| -2% | -$111M | 0.49% | 40 |
|
|
2020
Q2 | $6B | Buy |
16,562,306
+58,542
| +0.4% | +$19.6M | 0.44% | 45 |
|
|
2020
Q1 | $4.68B | Buy |
16,503,764
+165,895
| +1% | +$52.3M | 0.41% | 51 |
|
|
2019
Q4 | $5.31B | Buy |
16,337,869
+224,799
| +1% | +$68.2M | 0.36% | 56 |
|
|
2019
Q3 | $4.7B | Sell |
16,113,070
-125,719
| -0.8% | -$36M | 0.35% | 57 |
|
|
2019
Q2 | $4.77B | Sell |
16,238,789
-168,307
| -1% | -$46.4M | 0.36% | 55 |
|
|
2019
Q1 | $4.49B | Buy |
16,407,096
+775,253
| +5% | +$193M | 0.35% | 59 |
|
|
2018
Q4 | $3.5B | Buy |
15,631,843
+96,199
| +0.6% | +$22.6M | 0.32% | 64 |
|
|
2018
Q3 | $3.79B | Buy |
15,535,644
+758,451
| +5% | +$174M | 0.29% | 75 |
|
|
2018
Q2 | $3.06B | Sell |
14,777,193
-305,305
| -2% | -$64.8M | 0.26% | 79 |
|
|
2018
Q1 | $3.11B | Sell |
15,082,498
-862,415
| -5% | -$181M | 0.26% | 76 |
|
|
2017
Q4 | $3.03B | Buy |
15,944,913
+157,424
| +1% | +$30.2M | 0.24% | 83 |
|
|
2017
Q3 | $2.99B | Sell |
15,787,489
-176,208
| -1% | -$31.9M | 0.26% | 82 |
|
|
2017
Q2 | $2.79B | Sell |
15,963,697
-122,257
| -0.8% | -$20.5M | 0.25% | 83 |
|
|
2017
Q1 | $2.47B | Buy |
16,085,954
+164,367
| +1% | +$25.1M | 0.22% | 94 |
|
|
2016
Q4 | $2.25B | Buy |
15,921,587
+586,414
| +4% | +$86.5M | 0.21% | 99 |
|
|
2016
Q3 | $2.44B | Buy |
15,335,173
+324,006
| +2% | +$49.9M | 0.25% | 86 |
|
|
2016
Q2 | $2.22B | Sell |
15,011,167
-114,377
| -0.8% | -$16.9M | 0.24% | 89 |
|
|
2016
Q1 | $2.14B | Sell |
15,125,544
-255,388
| -2% | -$34.2M | 0.23% | 93 |
|
|
2015
Q4 | $2.18B | Buy |
15,380,932
+59,041
| +0.4% | +$7.87M | 0.24% | 84 |
|
|
2015
Q3 | $1.87B | Sell |
15,321,891
-129,178
| -0.8% | -$16.8M | 0.22% | 96 |
|
|
2015
Q2 | $2B | Sell |
15,451,069
-593,779
| -4% | -$77.4M | 0.21% | 98 |
|
|
2015
Q1 | $2.16B | Sell |
16,044,848
-912,606
| -5% | -$118M | 0.22% | 95 |
|
|
2014
Q4 | $2.12B | Buy |
16,957,454
+980,025
| +6% | +$119M | 0.21% | 102 |
|
|
2014
Q3 | $1.94B | Buy |
15,977,429
+316,177
| +2% | +$38.4M | 0.21% | 102 |
|
|
2014
Q2 | $1.85B | Buy |
15,661,252
+426,870
| +3% | +$50.2M | 0.2% | 113 |
|
|
2014
Q1 | $1.83B | Buy |
15,234,382
+620,417
| +4% | +$73.8M | 0.21% | 101 |
|
|
2013
Q4 | $1.63B | Buy |
14,613,965
+313,710
| +2% | +$31.2M | 0.18% | 116 |
|
|
2013
Q3 | $1.32B | Sell |
14,300,255
-725
| -0% | -$65.6K | 0.16% | 135 |
|
|
2013
Q2 | $1.21B | Buy |
+14,300,980
| New | +$1.19B | 0.16% | 134 |
|
Other funds holding TMO
VCM
VPM
State Street's TMO Position: Q1 2026 in Review
State Street increased its Thermo Fisher Scientific (TMO) stake by 0.71% in Q1 2026, buying an estimated $64M and bringing the position to 16,731,668 shares worth $8.23B. The position accounts for 0.28% of the portfolio, ranked #63.
State Street first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.8B in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- State Street held 16,731,668 shares of Thermo Fisher Scientific worth $8.23B as of Q1 2026.
- State Street bought 117,907 Thermo Fisher Scientific shares in Q1 2026, an estimated $64M.
- Thermo Fisher Scientific made up 0.28% of State Street's portfolio in Q1 2026, its #63 holding.
- State Street first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- State Street's Thermo Fisher Scientific position peaked at $10.8B in Q4 2021.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.